MEDIPOSTCO.,LTD.
Develops stem cell therapeutics and regenerative medicine for incurable diseases.
078160 | KO
Overview
Corporate Details
- ISIN(s):
- KR7078160009
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로 644번길21 -, 성남시
- Website:
- https://en.medi-post.co.kr/
- Sector:
- Manufacturing
Description
MEDIPOST is a biotechnology company specializing in the research, development, and commercialization of stem cell therapeutics and regenerative medicine. The company focuses on addressing unmet medical needs for incurable diseases through its proprietary stem cell platform technology. Its core operations include a cord blood banking service and the development of allogeneic stem cell therapies. Key commercialized products include CARTISTEM®, a treatment for knee cartilage defects and osteoarthritis, and PNEUMOSTEM®, a preventive therapy for bronchopulmonary dysplasia in premature infants. The company's clinical pipeline features next-generation injectable treatments for conditions such as osteoarthritis and diabetic nephropathy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-20 00:00 |
사업보고서 (2024.12)
|
Korean | 735.7 KB | ||
| 2025-03-17 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2025-03-13 00:00 |
주주총회소집공고
|
Korean | 1.4 MB | ||
| 2025-03-13 00:00 |
의결권대리행사권유참고서류
|
Korean | 1.4 MB | ||
| 2025-03-12 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 40.8 KB | ||
| 2025-03-12 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 44.4 KB | ||
| 2025-03-12 00:00 |
주주총회소집결의
|
Korean | 22.1 KB | ||
| 2025-03-12 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.8 KB | ||
| 2025-03-12 00:00 |
유상증자결정(종속회사의주요경영사항)
|
Korean | 20.3 KB | ||
| 2025-03-06 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2025-02-19 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.9 KB | ||
| 2025-02-04 00:00 |
[기재정정]기타경영사항(자율공시) (전환우선주 전환가액 조정)
|
Korean | 23.6 KB | ||
| 2024-12-24 00:00 |
투자판단관련주요경영사항 (카티스템®의 적응증 추가 국내 품목허가 변경 신청 결과)
|
Korean | 7.0 KB | ||
| 2024-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.2 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.7 MB |
Automate Your Workflow. Get a real-time feed of all MEDIPOSTCO.,LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for MEDIPOSTCO.,LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for MEDIPOSTCO.,LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
